Empirical therapy of L-AMB

2 trials

Sponsors

Center for Supporting Hematology-Oncology Trials, The first department of internal medicine, University of Fukui

Conditions

Hematological malignanciesfebrile neutropenia

Phase 2

Phase II study of liposomal amphotericin B for febrile neutropenia.(C-SHOT1001)

Active, not recruitingJPRN-UMIN000003185

Center for Supporting Hematology-Oncology TrialsHematological malignancies

Start: 2010-04-01Target: 80Updated: 2026-06-29

Unknown Phase

Empirical treatment of liposomal amphotericin B for febrile neutropenia. that persists despite broad-spectrum antibacterial therapy

RecruitingJPRN-UMIN000005163

The first department of internal medicine, University of Fukuifebrile neutropenia

Start: 2011-03-01Target: 50Updated: 2026-06-29